(S)-(+)-3-Hydroxytetrahydrofuran CAS 86087-23-2 Maʻemaʻe > 99.0%(GC) Afatinib Amprenavir Fosamprenavir Intermediate

ʻO ka wehewehe pōkole:

Inoa Kemika: (S)-3-Hydroxytetrahydrofuran

CAS: 86087-23-2

ʻAi ʻole ʻaʻole i ka wai Yellwow māmā

Maʻemaʻe: >99.0%(GC) Maʻemaʻe Optical: >99.0% (GC)

Ka waena o Afatinib, Amprenavir, Fosamprenavir

Inquiry: alvin@ruifuchem.com


Huahana Huahana

Nā Huahana Pili

Huahana Huahana

wehewehe:

Mea Hana Hana;Huahana wela;Maʻemaʻe kiʻekiʻe a me ke kumu kūʻai hoʻokūkū
(S)-(+)-3-Hydroxytetrahydrofuran CAS 86087-23-2 
Afatinib CAS 439081-18-2,Afatinib Dimaleate CAS 850140-73-7Kūwaena Nui
Amprenavir (CAS 161814-49-9) a me Fosamprenavir (CAS 226700-79-4) Kūwaena

Na Waiwai Kemika:

Inoa Kimia (S)-3-Hydroxytetrahydrofuran
Nā huaʻōlelo like (S)-(+)-3-Hydroxytetrahydrofuran;(S)-Tetrahydrofuran-3-ol;(S)-(+)-Tetrahydro-3-Furanol
Helu CAS 86087-23-2
Helu CAT RF-CC101
Kūlana Kūʻai Ma ka waihona, hoʻonui ʻia a hiki i nā tona
ʻĀpana Molekala C4H8O2
Kaumaha Molecular 88.11
Lae paila 80 ℃/15 mmHg(māmā)
ʻO ka mānoanoa 1.103 g/mL ma 25 ℃ (māmā)
Hōʻike Hōʻike n20/D 1.45 (māmā)
Hiki i ka wai Hiki ke hoʻoheheʻe
Kūlana Hoʻouna Hoʻouna ʻia ma lalo o ka wela ambient
Brand Kemika Ruifu

Nā kikoʻī:

'ikamu Nā kikoʻī
Ka nana aku ʻAi ʻole ʻaʻole i ka wai Yellwow māmā
Maʻemaʻe / Kaʻina Hanana >99.0% (GC)
ʻIkepili Pono ka manawa paʻa o ka hāpana e kūlike me ka manawa paʻa o ka maʻamau kuhikuhi
Hoʻololi kikoʻī[α]D20 +17.5° ± 2.5° (C=2 in MeOH)
Maʻemaʻe Optical ee >99.0% (GC)
Māmā (KF) <0.50%
(R)-(-)-3-Hydroxytetrahydrofuran <0.15%
ʻO nā mea haumia ʻē aʻe <0.40%
Huina haumia <1.00%
Kūlana hoʻāʻo Kūlana ʻoihana
Hoʻohana IIwaena o Afatinib, Afatinib Dimaleate, Amprenavir a me Amprenavir Phosphate

(S)-(+)-3-Hydroxytetrahydrofuran CAS 86087-23-2 ROS

86087-23-2 ROS

Pūʻolo a me ka waiho ʻana:

Pūʻolo: 'Omole, Fluoride Barrels, 25kg / Barrel, ai'ole e like me ka makemake o ka mea kū'ai.

Kūlana mālama:E mālama i loko o nā pahu i hoʻopaʻa ʻia ma kahi maloʻo a maloʻo;Palekana mai ka malamalama, ka ma'ū a me ka pest infestation.

Pono:

ʻO ka mana kūpono: lawa nā lako a me nā ʻenehana

ʻOihana Hoʻonaʻauao: Hoʻokahi lawelawe kūʻai kūʻai

Puke OEM: Loaʻa ka pūʻolo maʻamau a me ka lepili

Hoʻouna wikiwiki: Inā i loko o ke kumukūʻai, ʻekolu lā hoʻouna i hōʻoia ʻia

Hoʻolako Paʻa: E mālama i ka waiwai kūpono

Kākoʻo ʻenehana: Loaʻa ka hopena ʻenehana

Hana Hana Hana Kuʻuna: Mai ka grama a hiki i ke kilo

Kūlana Kiʻekiʻe: Hoʻokumu i kahi ʻōnaehana hōʻoia maikaʻi piha

FAQ:

121

Noi:

ʻO Shanghai Ruifu Chemical Co., Ltd. ka mea hana alakaʻi a me ka mea hoʻolako o (S)-(+)-3-Hydroxytetrahydrofuran (CAS: 86087-23-2) me ke kūlana kiʻekiʻe, hoʻohana nui ʻia i ka synthesis o nā intermediates pharmaceutical a me Active Pharmaceutical Mea hoʻohana (API).(S)-(+)-3-Hydroxytetrahydrofuran ka mea waena nui o Afatinib (CAS 439081-18-2), Afatinib Dimaleate (CAS: 850140-73-7), Amprenavir (CAS 161814-49-9) a me Fosamprenavir CAS 226700-79-4).ʻO Afatinib (CAS 439081-18-2) he mea ikaika, covalent / ireversible, a me ka waha bioavailable dual (EGFR / ErbB) receptor tyrosine kinase (RTK) inhibitor me ka hana anticancer.ʻO ka Afatinib (CAS 439081-18-2) kahi lāʻau lapaʻau i hiki ke lawe waha ʻia no ka mālama ʻana i ka maʻi maʻi ʻaʻai liʻiliʻi liʻiliʻi liʻiliʻi (NSCLC) me nā atypical Epidermal Growth Factor Receptor (EFGR).ʻO Amprenavir (CAS 161814-49-9) he mea hoʻopaneʻe protease HIV i hoʻohana ʻia e mālama i ka maʻi HIV.ʻO Amprenavir kekahi mea hoʻopaneʻe SARS-CoV 3CLpro me kahi IC50 o 1.09 μM.ʻO ka Fosamprenavir (Amprenavir phosphate; GW 433908) he mea hoʻolalelale phosphate ester o ka mea hoʻopiʻi protease antiretroviral Amprenavi.

E kākau i kāu leka ma aneʻi a hoʻouna mai iā mākou